Form 483

Pacific BioLabs, Inc. Form 483, 2018-03-19

FDA issued a Form 483 to Pacific BioLabs, Inc. on 2018-03-19 with 4 public-safe observations.

483· Form 483 issuedHuman Drugs4 observations

Pacific BioLabs, Inc. · Hercules, United States · Issued March 19, 2018

Overview

  • 4 public-safe observations are available for this inspection.
  • 4 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

19 Mar 2018
21 CFR 211.160(a)

Lab controls established, including changes

Cited by Ashar P Parikh

19 Mar 2018
21 CFR 211.160(b)(4)

Instruments, apparatus, et. al. not meeting specs

Cited by Ashar P Parikh

19 Mar 2018
21 CFR 211.192

Written record of investigation incomplete

Cited by Ashar P Parikh

19 Mar 2018
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Ashar P Parikh

Inspected site

PBPacific BioLabs, Inc.Hercules, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.160(a)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)(4)Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 4 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere